StayCurrentMD · CD200 expression predicts poor prognosis in neuroblastoma: a potential biomarker for treatment stratification—a retrospective cohort study
Follow
Article·Published Jan 2026

CD200 expression predicts poor prognosis in neuroblastoma: a potential biomarker for treatment stratification—a retrospective cohort study

link.springer.com shows its articles on its own site.

Read the article on link.springer.com ↗

Article · Jan 2026

In brief

In brief

Retrospective study identifying CD200 expression as a prognostic biomarker in neuroblastoma patients, with potential implications for risk stratification and treatment planning in pediatric oncology.

Written by the GCMD Library team from the article.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →